Burt/Northwestern stem cell/MS program no longer taking new patients

In a story titled Northwestern University Stem Cell Therapy Clinic Closes Abruptly , The Scientist reports that
Northwestern Medicine’s immunotherapy and autoimmune diseases program is no longer accepting new patients. The program was testing hematopoietic stem cell transplantations (HSCT) for treatment of multiple sclerosis (MS).

Included within the article is the text:


Some in the field question why the program can’t continue without him [Burt].
“If his program is so successful, [why] it should suddenly stop if he’s not there
is a little bizarre,” remarks Mark Freedman, a neurologist who directs a
research division focused on multiple sclerosis at Ottawa Hospital.
Burt and Northwestern did not say why the program could not continue without him.



See also

https://ipscell.com/2019/01/upbeat-burt-team-pub-on-stem-cells-for-ms-comes-with-uneasy-back-story/